中文
| Catalogue |
|
|
| Recommend Products |
Mainz Biomed N.V.
Germany, Manufacturer, Hits: 25, Updated:9/24/2025
Sirius Gutenberg Park Robert-Koch-Stra?e 50 55129, Mainz, Germany |
Company Profile
-
Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert?, an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer. ColoAlert? is marketed across Europe. The Company is currently running its eAArly DETECT 2 clinical study in preparation for it pivotal FDA study for US regulatory approval. Mainz Biomed’s product candidate portfolio also includes PancAlert, an early-stage pancreatic cancer screening test based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in blood and stool samples. To learn more, visit mainzbiomed.com or follow us on LinkedIn, Twitter and Facebook.